VR Logo

Integra LifeSciences Holdings Corporation (IART) download report


Healthcare | Medical Devices & Equipment

Integra LifeSciences Holdings Corporation (IART) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.

IPO Date: 16-Aug-1995

Pres, CEO & Director: Mr. Jan De Witte

Exec. VP, CFO & Treasurer: Ms. Carrie L. Anderson

Listing: NASDAQ: IART

Country: United States

Headquarters: Princeton, NJ

Website: https://www.integralife.com

Key Facts

Market cap: $4,653.71 Mln

Revenue (TTM): $1,566.84 Mln

Earnings (TTM): $166.30 Mln

Cash: $447.15 Mln

Total Debt: $1,037.05 Mln

Insider's Holding: 13.01%

Liquidity: Low

52 Week range: $51.21 - 76.70

Shares outstanding: 83,135,104

10 Years Aggregate:

  • CFO: $1,464.25 Mln
  • EBITDA: $1,546.49 Mln
  • Net Profit: $607.99 Mln

Stock Performance

Time Period Integra LifeSciences Holdings (IART) S&P BSE Sensex* S&P Small-Cap 600*
YTD-16.811.03-11.58
1 month1.338.638.86
3 months-9.687.32-2.19
1 Year-19.648.43-6.23
3 Years-3.6917.069.73
5 Years2.5712.777.72
10 Years15.2612.8310.81
As on 05-Aug-2022 *As on 08-Aug-2022
Year Integra LifeSciences Holdings (IART) S&P Small-Cap 600 S&P BSE Sensex
20213.1925.2721.99
202011.399.5715.75
201929.2220.8614.38
2018-5.74-9.705.87
201711.5711.7327.91
201626.5724.741.95
201575.63-3.36-5.03